Currently Viewing:
Newsroom
Currently Reading
Survey Identifies Americans' Preferences for Pain Management
November 20, 2017 – Jaime Rosenberg
How the Gut Microbiome Is Affecting Immunotherapy Response
November 20, 2017 – Laura Joszt
What We're Reading: Mandate Repeal Uncertainty; Destroying Antitrust Evidence; PTSD After Cancer
November 20, 2017 – AJMC Staff
This Week in Managed Care: November 17, 2017
November 17, 2017
Study Supports Use of Intravenous Golimumab in Treating Psoriatic Arthritis
November 17, 2017 – Kelly Davio
ASCO's TAPUR Study Expands to Enroll Patients Receiving Immunotherapy
November 17, 2017 – AJMC Staff
AJMC® in the Press, November 17, 2017
November 17, 2017 – AJMC Staff
What We're Reading: Gene Therapy Guidelines; Opioid Overdose Costs; Unaware of Open Enrollment
November 17, 2017 – AJMC Staff
5 Things About the New Hypertension Guidelines
November 17, 2017 – Mary Caffrey

Comorbidities Associated With Psoriasis Create Burden Among Patients

Alison Rodriguez
Psoriasis, an inflammatory skin disease, is often linked to many comorbidities that affect treatment decisions and the overall management of the disorder, according to new research.
Psoriasis, an inflammatory skin disease, is often linked to many comorbidities that affect treatment decisions and the overall management of the disorder, according to new research.

A study published by the Journal of the American Academy of Dermatology utilizes the Truven Health Analytics MarketScan database to identify the prevalence of comorbidities among psoriasis patients. The database includes US administrative claims for commercially insured adults, their dependents, and those with Medicare supplemental insurance.

Patients at least 18 years old who were diagnosed with psoriasis between July 1, 2008, and June 30, 2014, were included in the study and referred to as the psoriasis population. Psoriasis patients enrolled in a continuous health plan 6 months before through 6 months following the index date of diagnosis were included as the continuously enrolled population.

The review found 1.22 million patients had at least 1 claim of a psoriasis diagnosis between January 1, 2008 and December 31, 2014. Of these, 469,097 adult patients (at least 18 years old) had at least 2 claims of psoriasis diagnosis, while 292,999 patients met the criteria for the continuously enrolled population and made up 4.1% of adult psoriasis patients in the US in 2010.

The study analyzed the prevalence of 24 comorbidities in the total 469,097 adult psoriasis patients during the study period and found the most common comorbidities to be hyperlipidemia (45.6%), hypertension (42.2%), depression (17.9%), type 2 diabetes mellitus (17.5%), and obesity (14.4%).

“Medical insurance claims databases can be utilized to study large populations of patients and provide an effective means to assess comorbidity rates in real-world patients,” the study notes.

By detailing the high rates of comorbidities experienced by psoriasis patients, clinicians and healthcare professionals will be more knowledgeable and prepared to provide necessary care for patients.

“The use of very large insurance claims databases for determination of comorbidity prevalence may aid health care professionals in providing more comprehensive management of psoriasis,” the study concludes.

 
Copyright AJMC 2006-2017 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!